International Journal of Infectious Diseases
Volume 12, Issue 6 , Pages e71-e76 , November 2008

Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies

  • Kailapuri G. Murugavel

      Affiliations

    • Infectious Diseases Laboratory, YRG Centre for AIDS Research & Education, VHS Hospital Campus, Taramani, Chennai 600 113, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 44 22542929; fax: +91 44 22542939.
    • ,
  • S. Mathews

      Affiliations

    • Medical and Surgical Gastroenterology Units of the Government General Hospital, Chennai, India
    • ,
  • V. Jayanthi

      Affiliations

    • Government Stanley Medical College and Hospital, Chennai, India
    • ,
  • Esaki Muthu Shankar

      Affiliations

    • Infectious Diseases Laboratory, YRG Centre for AIDS Research & Education, VHS Hospital Campus, Taramani, Chennai 600 113, India
    • ,
  • R. Hari

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Dr ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, India
    • ,
  • R. Surendran

      Affiliations

    • Government Stanley Medical College and Hospital, Chennai, India
    • ,
  • Appasamy Vengatesan

      Affiliations

    • Government Stanley Medical College and Hospital, Chennai, India
    • ,
  • K. Raghuram

      Affiliations

    • Medical and Surgical Gastroenterology Units of the Government General Hospital, Chennai, India
    • ,
  • P. Rajasambandam

      Affiliations

    • Medical and Surgical Gastroenterology Units of the Government General Hospital, Chennai, India
    • ,
  • A. Murali

      Affiliations

    • Government Stanley Medical College and Hospital, Chennai, India
    • ,
  • Usha Srinivas

      Affiliations

    • Government Stanley Medical College and Hospital, Chennai, India
    • ,
  • K.R. Palaniswamy

      Affiliations

    • Department of Digestive Health and Diseases, Government Peripheral Hospital, Chennai, India
    • ,
  • T. Pugazhendhi

      Affiliations

    • Medical and Surgical Gastroenterology Units of the Government General Hospital, Chennai, India
    • ,
  • Sadras Panchatcharam Thyagarajan

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Dr ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, India
    • Sri Ramachandra Medical College and Hospital, Porur, Chennai, India

Received 30 November 2007 ,Revised 30 April 2008 ,Accepted 30 April 2008.

References 

  1. Romano PR, McCallus DE, Pachuk CJ. RNA interference-mediated prevention and therapy for hepatocellular carcinoma. Oncogene. 2006;25:3857–3865
  2. Dhir V, Mohandas KM. Epidemiology of digestive cancer in India—III. Liver. Indian J Gastroenterol. 1998;17:100–103
  3. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease. BMC Cancer. 2002;2:37
  4. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27–34
  5. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22:5093–5107
  6. Chen DS, Sung JL. Hepatitis B virus infection in Taiwan. N Engl J Med. 1977;297:668–669
  7. Murugavel KG, Naranatt PP, Shankar EM, Mathews S, Jayanthi V, Surendran R, et al. Prevalence of aflatoxin B1 in liver biopsies of proven hepatocellular carcinoma cases in India determined by an in-house immunoperoxidase test. J Med Microbiol. 2007;56:1455–1459
  8. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and β-catenin mutations. Int J Cancer. 2004;112:44–50
  9. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer. 1989;64:1700–1707
  10. Furukawa R, Tajima H, Nakata K, Kono K, Muro T, Sato A, et al. Clinical significance of serum alpha-fetoprotein in patients with liver cirrhosis. Tumour Biol. 1984;5:327–338
  11. Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology. 1986;90:263–267
  12. Panchanadam M, Madanagopalan N, Thyagarajan SP, Hill PG, Arumugam S. Correlated clinical, histopathological, HBV and AFP studies of primary carcinoma liver. Ann Acad Med Singapore. 1980;9:210–214
  13. Lee SD, Tong MJ, Wu JC, Lin HC, Tsai YT, Lo KJ. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. J Hepatol. 1991;12:246–250
  14. Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, et al. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral aetiology influence AFP levels in HCC? A study in 350 Western patients. Hepatogastroenterology. 2000;47:1654–1658
  15. Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res. 2003;23:1747–1753
  16. Nishi S, Watabe H, Hirai H. Species cross-reaction of alpha-fetoproteins and break-down of the tolerance to alpha-fetoprotein by immunization with heterologous alpha-fetoprotein. Tumour Res. 1973;8:17–22
  17. Lehmann FG, Wegener T. Aetiology of human liver cancer: controlled prospective study in liver cirrhosis. J Toxicol Environ Health. 1979;5:281–299
  18. Silver HK, Deneault J, Gold P, Thompson WG, Shuster J, Freedman SO. The detection of alpha 1-fetoprotein in patients with viral hepatitis. Cancer Res. 1974;34:244–247
  19. Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, et al. Hepatocellular carcinoma in Germany. Epidemiology, aetiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol. 1997;35:1059–1067
  20. Kapoor D, Aggarwal SR, Singh NP, Thakur V, Sarin SK. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepatol. 1999;6:405–409
  21. Francioni S, Pastore M. Alpha-fetoprotein and acute viral hepatitis type B. J Nucl Med Allied Sci. 1989;33:103–106
  22. Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, et al. Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem. 2005;280:6409–6415
  23. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 2003;125:89–97
  24. Khien VV, Mao HV, Chinh TT, Ha PT, Bang MH, Lac BV, et al. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers. 2001;16:105–111
  25. Oka H, Saito A, Ito K, Kumada T, Satomura S, Kasugai H, et al. Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J Gastroenterol Hepatol. 2001;16:1378–1383
  26. Yamashiki N, Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, et al. Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma. Oncol Rep. 1999;6:1229–1232

PII: S1201-9712(08)01374-X

doi: 10.1016/j.ijid.2008.04.010

International Journal of Infectious Diseases
Volume 12, Issue 6 , Pages e71-e76 , November 2008

Article Tools